Source: Health Products Regulatory Authority (IE) Revision Year: 2015 Publisher: Takeda UK Limited, Building 3, Glory Park, Glory Park Avenue, Wooburn Green, BUCKS HP10 0DF, United Kingdom
Xefo 4 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White to yellowish oblong film-coated tablet with imprint “L04”. |
One film-coated tablet contains 4 mg lornoxicam.
Excipients: 94 mg Lactose monohydrate.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Lornoxicam |
Lornoxicam is a non-steroidal anti-inflammatory drug with analgesic properties and belongs to the class of oxicams. Lornoxicams mode of action is mainly related to the inhibition of the prostaglandin synthesis (inhibition of the cyclooxygenase enzyme) leading to desensitisation of peripheral nociceptors and consequently inhibition of inflammation. A central effect on nociception, which seems to be independent of anti-inflammatory effects has also been suggested. |
| List of Excipients |
|---|
|
Core: Lactose monohydrate Film: Macrogol |
Blister: Opaque PVC/Aluminium. Each blister strip contains 10 film-coated tablets.
Pack sizes: 10, 20, 30, 50 and 100 film-coated tablets.
Not all pack sizes may be marketed.
Takeda UK Limited, Building 3, Glory Park, Glory Park Avenue, Wooburn Green, BUCKS HP10 0DF, United Kingdom
PA 1547/005/001
Date of First Authorisation: 22 May 2009
Date of last renewal: 17 January 2011
| Drug | Countries | |
|---|---|---|
| XEFO | Austria, Brazil, Estonia, Israel, Lithuania, Poland, Romania, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
